Penn Center for Innovation

Quarterly Patents (July, August, September 2016)

Posted on October 5, 2016 — Kat Hinkel

We are proud to recognize the following inventors who have been issued patents in the last quarter. Congratulations!   Foreign Patents Country PI Patent # Patent Title Issue Date Australia Czerniecki 2011227447 SYSTEM AND METHOD OF PREPARING AND STORING ACTIVATED MATURE DENDRITIC CELLS  7/29/2016 Australia Weiner 2013245950 Human Respiratory Synctial Virus Concensus Antigens, Nucleic Acid…

Read More

News Roundup, week of June 27

Posted on July 5, 2016 — Kat Hinkel

Conceptual Rendering of Pennovation Center East and North Facades_day

Last week, PCI and Penn technologies were featured in several news items. Here’s a list of what you might have missed: Featuring stories about the forthcoming Pennovation Center, a new Zika test invented by Penn researchers, a new partnership with top cancer centers, and more information about AAV 3.0. June 30 – Technically Philly – These 3…

Read More

Rescufy Launches Anaphylaxis Emergency Mobile App

Posted on June 30, 2016 — Kat Hinkel

Rescufy, a PCI Ventures company and inaugural AppItUP winner, has launched a groundbreaking new mobile app that will dramatically reduce the steps and response times in an anaphylaxis action plan during a life-threatening emergency.  In the event of a severe allergic reaction, with just the tap of a button on a smart phone’s home screen,…

Read More

Biogen Alliance

Posted on June 1, 2016 — Kat Hinkel

PCI facilitated a sizable multi-year collaborative alliance between Biogen and Penn Medicine faculty focused on gene therapy and gene editing. The collaboration has multiple main objectives: developing therapeutic approaches that target the eye, skeletal muscle and the central nervous system (CNS); validating next-generation gene transfer technology using adeno-associated virus (AAV) gene delivery vectors; and exploring…

Read More

SERES Therapeutics, Inc.

Posted on May 12, 2016 — Kat Hinkel

PCI negotiated a multi-year collaboration with Seres Therapeutics, Inc. a leading microbiome therapeutics platform company to support the development of novel treatment approaches for certain rare genetic metabolic diseases including urea cycle disorders, and inflammatory bowel disease (IBD). Under the terms of the agreement, Penn Professors Gary D. Wu, M.D., and James Lewis, M.D., two global…

Read More

Dimension Therapeutics

Posted on May 6, 2016 — Kat Hinkel

PCI facilitated a new research collaboration between Dimension Therapeutics and Penn Medicine to advance certain gene therapies for inherited metabolic diseases.  Dimension’s collaboration will focus on research conducted with Dr. James Wilsonand  will include programs designed to treat citrullinemia type 1, phenylketonuria (PKU), and Wilson disease, a rare genetic disease associated with the liver that…

Read More

Parker Institute for Cancer Immunotherapy

Posted on April 13, 2016 — Kat Hinkel

Penn is a founding partner of the Parker Institute for Cancer Immunotherapy, which unites six of the nation’s top medical schools and cancer centers around the shared aim of accelerating breakthroughs in cures for cancer through immunotherapy approaches.  The effort is backed by as much as $250 million in support from the Parker Foundation, making…

Read More

ARPA-E Energy Innovation Summit

Posted on February 26, 2016 — Kat Hinkel

February 29 – March 2: ARPA-E Energy Innovation Summit The ARPA-E Energy Innovation Summit is an annual conference and technology showcase that brings together experts from different technical disciplines and professions to think about America’s energy challenges in new and innovative ways. Now in its seventh year, the Summit offers a unique, three-day program aimed at…

Read More

I-Corps Blog: Sonosolve

Posted on — Kat Hinkel


Sonosolve, one of the teams in the Spring 2016 Penn I-Corps Site Accelerator, has been documenting their experience so far.  Week 1: Catheters are used widely in medicine and surgery. Indwelling catheters may become colonized by bacteria through biofilm formation or obstructed with blood clots, proteinaceous debris, or other bodily contents requiring flushing and/or surgical…

Read More

I-Corps Blog: CPR Connect

Posted on February 23, 2016 — Kat Hinkel


CPR Connect, one of the teams in the Spring 2016 Penn I-Corps Site Accelerator, has been documenting their experience so far.  Week 1: CPR Connect, an innovative digital health technology, aims to reduce emergency response times and improve patient outcomes of cardiac arrest victims. Using a novel wearable device, our technology better locates victims of…

Read More